Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adjuvant Therapy”

3,393 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 3,393 results

Large-scale testing (Phase 3)Study completedNCT00775307
What this trial is testing

Adjuvant Pazopanib in Stage I NSCLC

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Intergroupe Francophone de Cancerologie Thoracique 142
Large-scale testing (Phase 3)Ended earlyNCT00066807
What this trial is testing

Premenopausal Endocrine Responsive Chemotherapy Trial

Who this might be right for
Breast Cancer
ETOP IBCSG Partners Foundation 29
Not applicableLooking for participantsNCT06930807
What this trial is testing

Liquid Biopsy-Based Novel Modality for Postoperative Management of Lung Cancer

Who this might be right for
Non-small Cell Lung CancerMinimal Residual DiseaseAdaptive Treatment
Peking University People's Hospital 1,000
Large-scale testing (Phase 3)WithdrawnNCT02678026
What this trial is testing

Pessary as Adjunctive Therapy to Cerclage for the Prevention of Preterm Birth

Who this might be right for
Preterm Birth
Federico II University
Large-scale testing (Phase 3)Study completedNCT06774885
What this trial is testing

Role of Folic Acid in the Management of Adjuvant Endocrine Therapy-Induced Hot Flashes in Breast Cancer Patients

Who this might be right for
THERAPY-INDUCED HOT FLASHES IN BREAST CANCER PATIENTS
Future University in Egypt 120
Not applicableStudy completedNCT00767585
What this trial is testing

An Open Label Non-Interventional Evaluation of the Effect of Adjuvant Hormonal Treatment of Postmenopausal Women Wih Early Breast Cancer With Aromatase Inhibitors on Bone Mineral Density and Bone Fracture Rate in Daily Practice

Who this might be right for
Breast CancerOsteoporosis
AstraZeneca 560
Early research (Phase 1)Looking for participantsNCT05911217
What this trial is testing

Evaluate the Efficacy and Safety of CT041 After Adjuvant Chemotherapy for Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
CARsgen Therapeutics Co., Ltd. 20
Not applicableStudy completedNCT02791750
What this trial is testing

5 Years Follow-up With Adjuvant Therapy for Women With Breast Invasive Carcinoma

Who this might be right for
Breast Cancer
Institut de Cancérologie de Lorraine 150
Large-scale testing (Phase 3)UnknownNCT02817425
What this trial is testing

A Efficacy and Tolerability Study of TEGAFOX Sequential S-1 in the Treatment of Adjuvant Chemotherapy for Gastric Cancer

Who this might be right for
Gastric Cancer
LanZhou University 300
Large-scale testing (Phase 3)Study completedNCT05001217
What this trial is testing

Chinese Herbal Medicine Treatment as Adjunct Therapy for Parkinson's Disease

Who this might be right for
Parkinson Disease
Hong Kong Baptist University 160
Post-approval studies (Phase 4)Study completedNCT00631150
What this trial is testing

A Phase IV-Pharmacovigilance Study of Keppra Greece - S.K.A.T.E.: Safety of Keppra as Adjunctive Therapy in Epilepsy

Who this might be right for
Epilepsy
UCB Pharma 35
Large-scale testing (Phase 3)Study completedNCT00171340
What this trial is testing

Zoledronic Acid in the Prevention of Cancer Treatment Related Bone Loss in Postmenopausal Women Receiving Letrozole for Breast Cancer.

Who this might be right for
Bone LossBreast Cancer
Novartis Pharmaceuticals 1,065
Not applicableLooking for participantsNCT05717790
What this trial is testing

Concurrent and Adjuvant Nimotuzumab Combined With Induction Chemotherapy Plus Chemoradiation in Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma by AJCC V8 Stage
Fourth Affiliated Hospital of Guangxi Medical University 288
Not applicableStudy completedNCT00269490
What this trial is testing

Yoga as a Therapy for Traumatic Experiences

Who this might be right for
Post-Traumatic Stress Disorder
Samueli Institute for Information Biology 7
Large-scale testing (Phase 3)Study completedNCT01661790
What this trial is testing

Intrapleural Bevacizumab and Cisplatin Therapy for Malignant Pleural Effusion Caused by Non-small Cell Lung Cancer

Who this might be right for
Malignant Pleural Effusion
Chinese PLA General Hospital 72
Testing effectiveness (Phase 2)Ended earlyNCT01852110
What this trial is testing

Efficacy and Safety of MK-7622 as Adjunct Therapy in Participants With Alzheimer's Disease (MK-7622-012)

Who this might be right for
Alzheimer's Disease
Merck Sharp & Dohme LLC 240
Not applicableLooking for participantsNCT06343597
What this trial is testing

Volume Outcome Relationships and Effects

Who this might be right for
Esophageal Cancer
Methodist Health System 30
Post-approval studies (Phase 4)UnknownNCT03691441
What this trial is testing

Comparative Effectiveness Trial of Transoral Head and Neck Surgery Followed by Adjuvant Radio(Chemo)Therapy Versus Primary Radiochemotherapy for Oropharyngeal Cancer

Who this might be right for
Oropharyngeal Cancer
Universitätsklinikum Hamburg-Eppendorf 280
Large-scale testing (Phase 3)Study completedNCT01564056
What this trial is testing

Adjuvant Systemic Treatment for (ER)-Positive HER2-negative Breast Carcinoma in Women Over 70 According to Genomic Grade (GG): Chemotherapy + Endocrine Treatment Versus Endocrine Treatment

Who this might be right for
Breast Cancer
UNICANCER 1,989
Large-scale testing (Phase 3)Study completedNCT00354302
What this trial is testing

Bone Mineral Density in Postmenopausal Women With Primary Breast Cancer Who Are Receiving Treatment on Clinical Trial

Who this might be right for
Breast CancerOsteoporosis
NCIC Clinical Trials Group 497
Next Page